John E. Kennedy
Net Worth

Last updated:

What is John E. Kennedy net worth?

The estimated net worth of Mr. John E. Kennedy is at least $10,302,114 as of 3 Mar 2022. He owns shares worth $537,098 as insider, has earned $4,035,716 from insider trading and has received compensation worth at least $5,729,300 in CONMED Corporation.

What is the salary of John E. Kennedy?

Mr. John E. Kennedy salary is $572,930 per year as Group Executive Vice President of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service in CONMED Corporation.

How old is John E. Kennedy?

Mr. John E. Kennedy is 67 years old, born in 1958.

What stocks does John E. Kennedy currently own?

As insider, Mr. John E. Kennedy owns shares in one company:

Company Title Shares Price per share Total value
CONMED Corporation (CNMD) Group Executive Vice President of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service 9,855 $54.5 $537,098

What does CONMED Corporation do?

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD logo
CNMD
CONMED Corporation
$54.5

John E. Kennedy insider trading

CONMED Corporation

Mr. John E. Kennedy has made 10 insider trades between 2015-2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 30,220 units of CNMD stock on 4 Dec 2019. As of 3 Mar 2022 he still owns at least 9,855 units of CNMD stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 5,092 $59.96 $305,316
Option
Options To Purchase Common Stock 1,790 $78.76 $140,980
Sale
Common Stock 832 $144.33 $120,083
Option
Common Stock 1,790 $78.76 $140,980
Option
Common Stock 832 $97.69 $81,278
Option
Options To Purchase Common Stock 5,092 $59.96 $305,316
Option
Options To Purchase Common Stock 832 $97.69 $81,278
Option
Common Stock 110 $78.76 $8,664
Option
Options To Purchase Common Stock 5,000 $41.93 $209,650
Option
Rsus (restricted Stock Units) 1,250 N/A N/A
Option
Rsus (restricted Stock Units) 1,050 N/A N/A
Option
Options To Purchase Common Stock 110 $78.76 $8,664
Sale
Common Stock 110 $145.5 $16,005
Option
Common Stock 5,000 $41.93 $209,650
Option
Options To Purchase Common Stock 308 $59.96 $18,468
Option
Rsus (restricted Stock Units) 1,250 N/A N/A
Option
Common Stock 308 $59.96 $18,468
Option
Common Stock 1,050 N/A N/A
Option
Common Stock 1,250 N/A N/A
Option
Common Stock 1,250 N/A N/A
Option
Common Stock 9,462 $69.59 $658,413
Sale
Common Stock 4,450 $147.72 $657,363
Option
Options To Purchase Common Stock 9,462 $69.59 $658,413
Sale
Common Stock 4,240 $69.59 $295,040
Option
Common Stock 200 $134.75 $26,950
Option
Common Stock 600 $78.8 $47,282
Option
Options To Purchase Common Stock 4,240 $41.93 $177,783
Option
Options To Purchase Common Stock 3,640 $41.93 $152,625
Sale
Options To Purchase Common Stock 3,640 $41.93 $152,625
Sale
Common Stock 4,940 $39.87 $196,958
Option
Options To Purchase Common Stock 5,438 $87.31 $474,792
Option
Common Stock 5,438 $87.31 $474,792
Option
Common Stock 2,500 N/A N/A
Option
Rsus (restricted Stock Units) 2,500 N/A N/A
Option
Common Stock 2,500 N/A N/A
Sale
Common Stock 1,589 $95 $150,955
Option
Sars (Stock Appreciation Rights) 4,880 $51.3 $250,344
Sale
Common Stock 4,940 $95.15 $470,051
Option
Common Stock 22,120 $75.16 $1,662,473
Option
Options To Purchase Common Stock 17,240 $81.12 $1,398,526
Option
Rsus (restricted Stock Units) 1,575 N/A N/A
Option
Common Stock 1,575 N/A N/A
Option
Common Stock 1,575 N/A N/A
Sale
Common Stock 5,965 $112.42 $670,585
Option
Common Stock 19,520 $51.3 $1,001,376
Option
Sars (Stock Appreciation Rights) 19,520 $51.3 $1,001,376
Option
Options To Purchase Common Stock 30,220 $47.25 $1,427,986
Option
Common Stock 30,220 $47.25 $1,427,986
Sale
Common Stock 11,354 $115.03 $1,306,051
Option
Rsus (restricted Stock Units) 600 N/A N/A
Option
Common Stock 600 N/A N/A
Option
Rsus (restricted Stock Units) 725 N/A N/A
Option
Common Stock 725 N/A N/A
Option
Common Stock 600 N/A N/A
Option
Rsus (restricted Stock Units) 600 N/A N/A
Option
Rsus (restricted Stock Units) 725 N/A N/A
Option
Common Stock 725 N/A N/A
Option
Rsus (restricted Stock Units) 560 N/A N/A
Option
Common Stock 560 N/A N/A
Option
Common Stock 725 N/A N/A
Option
Rsus (restricted Stock Units) 725 N/A N/A
Option
Common Stock 560 N/A N/A
Option
Rsus (restricted Stock Units) 560 N/A N/A
Option
Rsus (restricted Stock Units) 400 N/A N/A
Option
Common Stock 400 N/A N/A
Option
Rsus (restricted Stock Units) 560 N/A N/A
Option
Common Stock 560 N/A N/A

CONMED key executives

CONMED Corporation executives and other stock owners filed with the SEC:

  • Mr. Curt R. Hartman (61) Chairman, Chief Executive Officer & Pres
  • Mr. John E. Kennedy (67) Group Executive Vice President of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service
  • Mr. Patrick J. Beyer (59) Pres of International & Global Orthopedics
  • Mr. Stanley W. Peters III (50) Vice President & GM of U.S. Advanced Surgical
  • Mr. Todd W. Garner (56) Executive Vice President & Chief Financial Officer